Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial.

Hoy JF, Grund B, Roediger M, Schwartz AV, Shepherd J, Avihingsanon A, Badal-Faesen S, de Wit S, Jacoby S, La Rosa A, Pujari S, Schechter M, White D, Engen NW, Ensrud K, Aagaard PD, Carr A; INSIGHT START Bone Mineral Density Substudy Group.

J Bone Miner Res. 2017 Sep;32(9):1945-1955. doi: 10.1002/jbmr.3183. Epub 2017 Jun 26.

PMID:
28650589
2.

Reprint of: The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide.

Curtis EM, Moon RJ, Harvey NC, Cooper C.

Int J Orthop Trauma Nurs. 2017 Aug;26:7-17. doi: 10.1016/j.ijotn.2017.04.004. Epub 2017 Apr 26.

PMID:
28578992
3.

UK clinical guideline for the prevention and treatment of osteoporosis.

Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, Hope S, Kanis JA, McCloskey EV, Poole KES, Reid DM, Selby P, Thompson F, Thurston A, Vine N; National Osteoporosis Guideline Group (NOGG).

Arch Osteoporos. 2017 Dec;12(1):43. doi: 10.1007/s11657-017-0324-5. Epub 2017 Apr 19.

4.

A Prospective Observational Study on Effect of Short-Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO-01).

Nakamura M, Ishiguro A, Muranaka T, Fukushima H, Yuki S, Ono K, Murai T, Matsuda C, Oba A, Itaya K, Sone T, Yagisawa M, Koike Y, Endo A, Tsukuda Y, Ono Y, Kudo T, Nagasaka A, Nishikawa S, Komatsu Y.

Oncologist. 2017 May;22(5):592-600. doi: 10.1634/theoncologist.2016-0308. Epub 2017 Mar 24.

PMID:
28341762
5.

Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid: A nationwide osteoporosis survey.

Yu SF, Chen JF, Chen YC, Lai HM, Ko CH, Chiu WC, Su FM, Hsu CY, Su BY, Wu CH, Cheng TT.

Medicine (Baltimore). 2017 Feb;96(5):e5959. doi: 10.1097/MD.0000000000005959.

6.

Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis.

Yao L, Wang H, Dong W, Liu Z, Mao H.

Medicine (Baltimore). 2017 Jan;96(3):e5861. doi: 10.1097/MD.0000000000005861.

7.

One-year effects of glucocorticoids on bone density: a meta-analysis in cohorts on high and low-dose therapy.

Lems WF, Baak MM, van Tuyl LH, Lodder MC, Dijkmans BA, Boers M.

RMD Open. 2016 Sep 12;2(2):e000313. doi: 10.1136/rmdopen-2016-000313. eCollection 2016.

8.

Coracoid Process Avulsion Fracture at the Coracoclavicular Ligament Attachment Site in an Osteoporotic Patient with Acromioclavicular Joint Dislocation.

Onada Y, Umemoto T, Fukuda K, Kajino T.

Case Rep Orthop. 2016;2016:9580485. doi: 10.1155/2016/9580485. Epub 2016 Jul 17.

9.

Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.

Waljee AK, Wiitala WL, Govani S, Stidham R, Saini S, Hou J, Feagins LA, Khan N, Good CB, Vijan S, Higgins PD.

PLoS One. 2016 Jun 23;11(6):e0158017. doi: 10.1371/journal.pone.0158017. eCollection 2016.

10.

A review of the methods used to define glucocorticoid exposure and risk attribution when investigating the risk of fracture in a rheumatoid arthritis population.

Robinson DE, Dennison EM, Cooper C, van Staa TP, Dixon WG.

Bone. 2016 Sep;90:107-15. doi: 10.1016/j.bone.2016.06.001. Epub 2016 Jun 3. Review.

11.

Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer.

Christensen CØ, Cronin-Fenton D, Frøslev T, Hermann AP, Ewertz M.

Support Care Cancer. 2016 Oct;24(10):4229-36. doi: 10.1007/s00520-016-3250-y. Epub 2016 May 5.

12.

The Skeletal Effects of Inhaled Glucocorticoids.

Sutter SA, Stein EM.

Curr Osteoporos Rep. 2016 Jun;14(3):106-13. doi: 10.1007/s11914-016-0308-1. Review.

13.

The Developmental Origins of Osteoporosis.

Wood CL, Stenson C, Embleton N.

Curr Genomics. 2015 Dec;16(6):411-8. doi: 10.2174/1389202916666150817202217.

14.

The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis.

Lee JH, Sung YK, Choi CB, Cho SK, Bang SY, Choe JY, Hong SJ, Jun JB, Kim TH, Lee J, Lee HS, Yoo DH, Yoon BY, Bae SC.

BMC Musculoskelet Disord. 2016 Feb 24;17:98. doi: 10.1186/s12891-016-0952-8.

15.

Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management.

Lan GB, Xie XB, Peng LK, Liu L, Song L, Dai HL.

Biomed Res Int. 2015;2015:413169. doi: 10.1155/2015/413169. Epub 2015 Nov 15. Review.

16.

New perspectives in echographic diagnosis of osteoporosis on hip and spine.

Casciaro S, Conversano F, Pisani P, Muratore M.

Clin Cases Miner Bone Metab. 2015 May-Aug;12(2):142-50. doi: 10.11138/ccmbm/2015.12.2.142. Epub 2015 Oct 26. Review.

17.

THE EFFECT OF GLUCOCORTICOIDS ON BONE AND MUSCLE.

Klein GL.

Osteoporos Sarcopenia. 2015 Sep 1;1(1):39-45.

18.

Glucocorticoids: bad or safe for the bones?

Lems WF.

RMD Open. 2015 Aug 15;1(Suppl 1):e000050. doi: 10.1136/rmdopen-2015-000050. eCollection 2015.

19.

Glucocorticoid-induced osteoporosis.

Briot K, Roux C.

RMD Open. 2015 Apr 8;1(1):e000014. doi: 10.1136/rmdopen-2014-000014. eCollection 2015. Review.

20.

Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.

Lichtenstein GR, Hanauer SB, Sandborn WJ.

Gastroenterol Hepatol (N Y). 2015 Mar;11(3 Suppl 1):1-16.

Supplemental Content

Support Center